In addition, the 5-aza-dC treatment resulted in upregulation of ACAT1 at the mRNA level, further indicating that ACAT1 is inactivated by DNA hypermethylation in NPC. This evidence concerns the gene ACAT1 and nasopharyngeal carcinoma.